Solutions / Investment and M&A
Business developmentBusiness development and due diligence for pharma M&A
Conduct specialized market scans on new drug candidates, investigational devices, and biotechs as you explore licensing and pharma business development opportunities.
- 740,000+ trials
- Refreshed daily
- Source-traceable
- Deep China coverage
Broaden your aperture and diligence in detail
Scan the field for assets and biotechs that fit your thesis, then evaluate each one on source-traceable trial evidence you can defend in the deal room. Search and evaluation teams use TrialForge to move from long list to short list without leaving the platform.
Conduct specified market scans
Run comprehensive scans for new drug candidates, devices, and biotechs trimmed to your specific indication, modality, mechanism, and stage, across global registries.
Evaluate the asset
Pull full trial details behind a candidate or company from all global registries, and compare metrics to peer benchmarks.
An example scan, ready in minutes
Define your thesis and TrialForge assembles the trials, companies, and stage mix that fit, every figure traceable back to its registry record.
Asset funnel
TrialForge's coverage of cardiorenalmetabolic assets
Read the coverage audit